A Widely Inclusive, Hybrid-Decentralized Pilot Trial Utilizing β-hydroxy-β-methylbutyrate to Lower IGFBP7 Levels in People With ALS

Clinical trial NCT07589764 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07589764
Sponsor: Duke University
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis ALS

Start date: 2026-07-01
Primary completion: 2026-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.